[Federal Register: April 28, 2008 (Volume 73, Number 82)]
[Proposed Rules]
[Page 22845-22848]
[DOCID:fr28ap08-18]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2008-0414; Directorate Identifier 2007-NM-095-AD]
RIN 2120-AA64

Airworthiness Directives; Boeing Model 747-100, 747-100B, 747-
100B SUD, 747-200B, 747-200C, 747-200F, 747-300, 747-400, 747-400D,
747-400F, and 747SR Series Airplanes

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: The FAA proposes to supersede an existing airworthiness
directive (AD) that applies to certain Boeing Model 747 series
airplanes. The existing AD currently requires repetitive inspections
for cracking and corrosion of all exposed surfaces of the carriage
spindles (including the inner bore and aft links) of the trailing edge
flaps, and additional inspection and corrective action if necessary.
The existing AD also requires repetitive overhaul of the carriage
spindle and aft link, which terminates the repetitive inspections. This
proposed AD would add a repetitive inspection to detect broken parts,
and revise the overhaul threshold and repetitive intervals. This
proposed AD results from analysis that showed additional inspections
should be done to prevent the loss of a flap, and that the flight-hour-
based interval should be revised to a flight-cycle-based interval,
because the greatest loads on the spindles happen during takeoff and
landing. We are proposing this AD to detect and correct failed carriage
spindles or aft links for the inboard or outboard trailing edge flaps.
Such failure could cause the flap to depart the airplane, reducing the
flightcrew's ability to maintain the safe flight and landing of the
airplane.

DATES: We must receive comments on this proposed AD by June 12, 2008.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://
www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.
    For service information identified in this AD, contact Boeing
Commercial Airplanes, P.O. Box 3707, Seattle, Washington 98124-2207.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://
www.regulations.gov; or in person at the Docket Management Facility
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this proposed AD, the regulatory
evaluation, any comments received, and other information. The street
address for the Docket Office (telephone<PHONE_NUMBER>) is in the
ADDRESSES section. Comments will be available in the AD docket shortly
after receipt.

FOR FURTHER INFORMATION CONTACT: Gary Oltman, Aerospace Engineer,
Airframe Branch, ANM-120S, FAA, Seattle Aircraft Certification Office,
1601 Lind Avenue, SW., Renton, Washington 98057-3356; telephone (425)
917-6443; fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2008-0414;
Directorate Identifier 2007-NM-095-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD because of those comments.
    We will post all comments we receive, without change, to http://
www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    On August 6, 1990, we issued AD 90-17-19, amendment 39-6705 (55 FR
33280, August 15, 1990), for all Boeing Model 747 series airplanes,
except the Model 747SP. That AD requires repetitive inspections for
cracking and corrosion of all exposed surfaces of the carriage spindles
(including the inner bore and aft links) of the trailing edge flaps,
and additional inspection and corrective action if necessary. The
existing AD also requires repetitive overhaul of the carriage spindle
and aft link, which terminates the repetitive inspections. That AD
resulted from a report of failure of two aft links in the spindles on
one flap, causing control problems during approach and landing. We
issued that AD to prevent failure of the trailing edge flaps' carriage
spindles, which could result in reduced controllability of the
airplane.

Actions Since Existing AD Was Issued

    Since we issued AD 90-17-19, the manufacturer conducted a dynamic
aerodynamic analysis, which showed that the airplane might not have

sufficient roll authority to overcome loss of lift caused by a
departure of a single left- or right-hand inboard or outboard trailing
edge flap. The manufacturer then conducted a structural analysis of the
flap attach structure and fail-safe components, which showed that
additional inspections should be done to prevent the loss of a flap,
and that the flight-hour-based interval required by AD 90-17-19 should
be revised to a flight-cycle-based interval because the greatest loads
on the spindles happen during takeoff and landing and not during
flight.

Relevant Service Information

    We have reviewed Boeing Service Bulletin 747-27-2280, Revision 6,
dated February 14, 2008. We referred to Boeing Service Bulletin 747-27-
2280, Revision 3, dated November 30, 1989, as the appropriate source of
service information for accomplishing the actions required by AD 90-17-
19. Revision 6 adds a repetitive inspection of all eight carriage
spindles and aft links to detect a broken carriage spindle or aft link,
and corrective action if necessary. The remaining procedures in
Revision 6 of the service bulletin are unchanged from Revision 3 of the
service bulletin. The corrective action is replacing the broken part
before further flight.
    Revision 6 of the service bulletin also revises the overhaul
threshold and the repetitive overhaul interval as follows (AD 90-17-19
required the repetitive overhaul):
     The initial overhaul threshold is the earlier of 8 years
or a specified number of flight cycles. The number of flight cycles is
either 6,000 or 9,000, depending on the airplane group specified in the
service bulletin and the type and location of carriage originally
installed.
     The repetitive overhaul interval is also the earlier of 8
years or the same specified number of flight cycles based on the same
variables.
    We have also reviewed Boeing Service Bulletin 747-27-2371, dated
December 20, 2000, which applies only to Group 1 and Group 3 airplanes
identified in Boeing Service Bulletin 747-27-2280, Revision 6. Boeing
Service Bulletin 747-27-2371 describes procedures for replacing the
link assemblies with new link assemblies made from improved corrosion-
resistant steel (CRES) that has a bearing race that is machined into
the link. Doing this replacement eliminates the need for the repetitive
overhauls specified in Boeing Service Bulletin 747-27-2280, Revision 6,
for that aft link only.
    Accomplishing the actions specified in the service information is
intended to adequately address the unsafe condition.

FAA's Determination and Requirements of the Proposed AD

    We have evaluated all pertinent information and identified an
unsafe condition that is likely to develop on other airplanes of the
same type design. For this reason, we are proposing this AD, which
would supersede AD 90-17-19 and would retain certain requirements of
the existing AD at revised intervals. This proposed AD would also
require a repetitive inspection to detect a broken carriage spindle or
broken aft link, and corrective action if necessary. The proposed AD
would also include, for certain airplanes, procedures for replacing the
link assemblies with new link assemblies made from improved CRES that
has a bearing race that is machined into the link, which would end the
need for the repetitive overhauls specified in Boeing Service Bulletin
747-27-2280, Revision 6, for that aft link only.

Changes to Existing AD

    This proposed AD would retain certain requirements of AD 90-17-19.
Since AD 90-17-19 was issued, the AD format has been revised, and
certain paragraphs have been rearranged. As a result, the corresponding
paragraph identifiers have changed in this proposed AD, as listed in
the following table:

                      Revised Paragraph Identifiers
------------------------------------------------------------------------
                                             Corresponding  requirement
        Requirement in AD 90-17-19              in this  proposed AD
------------------------------------------------------------------------
paragraph A...............................  paragraph (f).
paragraph A.1.............................  paragraph (f).
paragraph A.2.............................  paragraph (f)(1).
paragraph A.3.............................  paragraph (f)(2).
paragraph A.4.............................  paragraph (f)(3).
paragraph A.5.............................  paragraph (f)(4).
paragraph B...............................  paragraph (g).
------------------------------------------------------------------------

    We have revised paragraph A.5. of AD 90-17-19 (paragraph (f)(4) of
this proposed AD) to allow any part of both carriage spindle/aft link
assemblies to be repaired according to data that conform to the
airplane's type certificate and that are approved by an Authorized
Representative for the Boeing Commercial Airplanes Delegation Option
Authorization Organization whom we have authorized to make such
findings.
    In this proposed AD, the ``detailed visual inspection'' specified
in AD 90-17-19 is referred to as a ``detailed inspection.'' We have
included the definition for a detailed inspection in Note 1 of the
proposed AD. We have also included the definition of a general visual
inspection in Note 2 of this AD. That definition was not included in AD
90-17-19.

Costs of Compliance

    There are about 925 airplanes of the affected design in the
worldwide fleet, which includes 160 airplanes of U.S. registry. The
following table provides the estimated costs for U.S. operators to
comply with this proposed AD. The average labor rate is $80 per work
hour.

                                                 Estimated Costs
----------------------------------------------------------------------------------------------------------------
              Action                      Work hours         Parts      Cost per airplane        Fleet cost
----------------------------------------------------------------------------------------------------------------
Inspection and overhaul (required   Between 120 and 140,          $0  Between $9,600 and    Between $1,536,000
 by AD 90-17-19).                    per flap per cycle.               $11,200, per flap     and $1,792,000, per
                                                                       per overhaul cycle.   flap per cycle.
Repetitive inspection for broken    2, per inspection              0  $160, per inspection  $25,600, per
 parts (new proposed action).        cycle.                            cycle.                inspection cycle.
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, Section 106, describes the
authority of the FAA Administrator. Subtitle VII, Aviation Programs,
describes in more detail the scope of the Agency's authority.
    We are issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701, ``General
requirements.'' Under that section, Congress charges the FAA with

promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We have determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify that the proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this proposed AD and placed it in the AD docket. See the
ADDRESSES section for a location to examine the regulatory evaluation.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

    1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

    2. The Federal Aviation Administration (FAA) amends Sec.  39.13 by
removing amendment 39-6705 (55 FR 33280, August 15, 1990) and adding
the following new airworthiness directive (AD):

Boeing: Docket No. FAA-2008-0414; Directorate Identifier 2007-NM-
095-AD.

Comments Due Date

    (a) The FAA must receive comments on this AD action by June 12,
2008.

Affected ADs

    (b) This AD supersedes AD 90-17-19.

Applicability

    (c) This AD applies to all Boeing Model 747-100, 747-100B, 747-
100B SUD, 747-200B, 747-200C, 747-200F, 747-300, 747-400, 747-400D,
747-400F, and 747SR series airplanes, certificated in any category.

Unsafe Condition

    (d) This AD results from analysis that showed that additional
inspections should be done to prevent the loss of a flap, and that
the flight-hour-based interval should be revised to a flight-cycle-
based interval, because the greatest loads on the spindles happen
during takeoff and landing. We are issuing this AD to detect and
correct failed carriage spindles or aft links for the inboard or
outboard trailing edge flaps. Such failure could cause the flap to
depart the airplane, reducing the flightcrew's ability to maintain
the safe flight and landing of the airplane.

Compliance

    (e) You are responsible for having the actions required by this
AD performed within the compliance times specified, unless the
actions have already been done.

Requirements of AD 90-17-19

Repetitive Inspections

    (f) For all airplanes except those airplanes on which the
repetitive overhauls required by paragraph B. of AD 90-17-19 are
being accomplished as of the effective date of this AD: Prior to the
accumulation of 30,000 flight hours or 8 years on each new or
previously overhauled flap carriage spindle, whichever occurs first,
remove the aft link and thrust collars from the trailing edge flaps'
carriage spindles and perform a detailed inspection of all exposed
surfaces of the carriage spindles, including inner bore, and aft
links to detect cracking and corrosion, in accordance with the
Accomplishment Instructions of Boeing Service Bulletin 747-27-2280,
Revision 3, dated November 30, 1989.

    Note 1: For the purposes of this AD, a detailed inspection is:
``An intensive examination of a specific item, installation, or
assembly to detect damage, failure, or irregularity. Available
lighting is normally supplemented with a direct source of good
lighting at an intensity deemed appropriate. Inspection aids such as
mirror, magnifying lenses, etc., may be necessary. Surface cleaning
and elaborate procedures may be required.''

    (1) If no cracking or corrosion is found, repeat the inspections
required by paragraph (f) of this AD at intervals not to exceed 12
months until the carriage spindles are overhauled in accordance with
paragraph (g) of this AD.
    (2) If a cracked carriage spindle or aft link is found, prior to
further flight, replace the part(s) in accordance with the service
bulletin.
    (3) If corrosion is found on any part of the carriage spindle/
aft link assembly, but not on the other assembly on the same flap,
perform a repetitive general visual inspection in accordance with
the service bulletin at intervals not to exceed 2 months. Overhaul
or replace corroded parts in accordance with the service bulletin
within 36 months after detection of the corrosion.
    (4) If corrosion is found on any part of both carriage spindle/
aft link assemblies on the same flap, prior to further flight,
overhaul or replace the part(s) in accordance with the service
bulletin or repair in accordance with the procedures specified in
paragraph (m) of this AD.

    Note 2: For the purposes of this AD, a general visual inspection
is: ``A visual examination of an interior or exterior area,
installation, or assembly to detect obvious damage, failure, or
irregularity. This level of inspection is made from within touching
distance unless otherwise specified. A mirror may be necessary to
ensure visual access to all surfaces in the inspection area. This
level of inspection is made under normally available lighting
conditions such as daylight, hangar lighting, flashlight, or
droplight and may require removal or opening of access panels or
doors. Stands, ladders, or platforms may be required to gain
proximity to the area being checked.''

Initial and Repetitive Overhauls

    (g) For all airplanes: Prior to the accumulation of 8 years or
30,000 flight hours on any new or previously overhauled flap
carriage spindle, whichever occurs later, remove the carriage
spindle and aft link, and overhaul in accordance with the
Accomplishment Instructions of Boeing Service Bulletin 747-27-2280,
Revision 3, dated November 30, 1989. Repeat the overhaul thereafter
at intervals not to exceed 8 years or 30,000 flight hours, whichever
occurs earlier. Accomplishment of initial overhaul required by this
paragraph terminates the requirements of paragraph (f) of this AD.

New Requirements of This AD

Terminating Requirements

    (h) The actions specified in paragraphs (i) and (j) of this AD
must be accomplished in their entirety, at the specified compliance
times, to terminate the requirements of paragraphs (f) and (g) of
this AD. There is no terminating action for the requirements of
paragraphs (i) and (j) of this AD.

Repetitive Inspection for Broken Parts

    (i) For all airplanes: Within 12 months or 400 flight cycles
after the effective date of this AD, whichever occurs earlier, do a
general visual inspection of all eight carriage spindles and aft
links to detect a broken carriage spindle or broken aft link, and do
all applicable corrective actions before further flight. Repeat the
inspection thereafter at intervals not to exceed 400 flight cycles.
Do all actions in accordance with the Accomplishment Instructions of
Boeing Service Bulletin 747-27-2280, Revision 6, dated February 14,
2008. For airplanes identified in Note (d) of Table 1 in paragraph
1.E., ``Compliance,'' of Boeing Service Bulletin 747-27-2280,
Revision 6, dated February 14, 2008, the initial compliance

time and repetitive interval for a flap may be extended to 1,000
flight cycles when new carriages are installed at both the inboard
and outboard carriage locations on the flap.

Repetitive Overhauls

    (j) For all airplanes: At the later of the times specified in
paragraph (j)(1) or (j)(2) of this AD, remove the carriage spindle
and aft link, and overhaul in accordance with the Accomplishment
Instructions of Boeing Service Bulletin 747-27-2280, Revision 6,
dated February 14, 2008. Repeat the overhaul thereafter at the
applicable repeat interval specified in paragraph 1.E.,
``Compliance,'' of Boeing Service Bulletin 747-27-2280, Revision 6,
dated February 14, 2008.
    (1) The applicable threshold specified in paragraph 1.E.
``Compliance,'' of Boeing Service Bulletin 747-27-2280, Revision 6,
dated February 14, 2008.
    (2) Within 48 months after the effective date of this AD.

Optional Terminating Action

    (k) For Groups 1 and 3 airplanes identified in Boeing Service
Bulletin 747-27-2280, Revision 6, dated February 14, 2008: Replacing
the existing 4340M aft link with a new corrosion resistant steel
(CRES) aft link in accordance with the Accomplishment Instructions
of Boeing Service Bulletin 747-27-2371, dated December 20, 2000,
terminates the repetitive inspection requirements of paragraph (f)
of this AD, and the repetitive overhaul requirements of paragraphs
(g) and (j) of this AD for that aft link only. The repetitive
inspections for broken parts required by paragraph (i) of this AD
cannot be terminated.

Credit for Previous Revision of Service Bulletin

    (l) Actions done before the effective date of this AD in
accordance with Boeing Service Bulletin 747-27-2280, Revision 4,
dated April 26, 2001, are acceptable for compliance with the
corresponding requirements of paragraphs (f) and (g) of this AD.
Actions done before the effective date of this AD in accordance with
Boeing Service Bulletin 747-27-2280, Revision 5, dated April 5,
2007, are acceptable for compliance with the corresponding
requirements of paragraphs (i) and (j) of this AD.

Alternative Methods of Compliance (AMOCs)

    (m)(1) The Manager, Seattle Aircraft Certification Office (ACO),
FAA, has the authority to approve AMOCs for this AD, if requested in
accordance with the procedures found in 14 CFR 39.19.
    (2) To request a different method of compliance or a different
compliance time for this AD, follow the procedures in 14 CFR 39.19.
Before using any approved AMOC on any airplane to which the AMOC
applies, notify your appropriate principal inspector (PI) in the FAA
Flight Standards District Office (FSDO), or lacking a PI, your local
FSDO.
    (3) AMOCs approved previously in accordance with AD 90-17-19 are
approved as AMOCs for the corresponding provisions of this AD.
    (4) Adjustments to the compliance times approved previously in
accordance with AD 90-17-19 are not approved for the corresponding
provisions of this AD.
    (5) An AMOC that provides an acceptable level of safety may be
used for any repair required by this AD, if it is approved by an
Authorized Representative for the Boeing Commercial Airplanes
Delegation Option Authorization Organization who has been authorized
by the Manager, Seattle ACO, to make those findings. For a repair
method to be approved, the repair must meet the certification basis
of the airplane, and the approval must specifically refer to this
AD.

    Issued in Renton, Washington, on April 18, 2008.
Ali Bahrami,
Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. E8-9122 Filed 4-25-08; 8:45 am]

BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 14 (Monday, January 23, 2012)]
[Rules and Regulations]
[Pages 3100-3102]
[FR Doc No: 2012-804]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 97

[Docket No. 30821; Amdt. No. 3460]

Standard Instrument Approach Procedures, and Takeoff Minimums and
Obstacle Departure Procedures; Miscellaneous Amendments

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This rule establishes, amends, suspends, or revokes Standard
Instrument Approach Procedures (SIAPs) and associated Takeoff Minimums
and Obstacle Departure Procedures for operations at certain airports.
These regulatory actions are needed because of the adoption of new or
revised criteria, or because of changes occurring in the National
Airspace System, such as the commissioning of new navigational
facilities, adding new obstacles, or changing air traffic requirements.
These changes are designed to provide safe and efficient use of the
navigable airspace and to promote safe flight operations under
instrument flight rules at the affected airports.

DATES: This rule is effective January 23, 2012. The compliance date for
each SIAP, associated Takeoff Minimums, and ODP is specified in the
amendatory provisions.
    The incorporation by reference of certain publications listed in
the regulations is approved by the Director of the Federal Register as
of January 23, 2012.

ADDRESSES: Availability of matters incorporated by reference in the
amendment is as follows:
    For Examination--
    1. FAA Rules Docket, FAA Headquarters Building, 800 Independence
Avenue SW., Washington, DC 20591;
    2. The FAA Regional Office of the region in which the affected
airport is located;
    3. The National Flight Procedures Office, 6500 South MacArthur
Blvd., Oklahoma City, OK 73169 or,
    4. The National Archives and Records Administration (NARA). For
information on the availability of this material at NARA, call (202)
741-6030, or go to: http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html.
    Availability--All SIAPs and Takeoff Minimums and ODPs are available
online free of charge. Visit http://www.nfdc.faa.gov to register.
Additionally, individual SIAP and Takeoff Minimums and ODP copies may
be obtained from:
    1. FAA Public Inquiry Center (APA-200), FAA Headquarters Building,
800 Independence Avenue SW., Washington, DC 20591; or
    2. The FAA Regional Office of the region in which the affected
airport is located.

FOR FURTHER INFORMATION CONTACT: Richard A. Dunham III, Flight
Procedure Standards Branch (AFS-420), Flight Technologies and Programs
Divisions, Flight Standards Service, Federal Aviation Administration,
Mike Monroney Aeronautical Center, 6500 South MacArthur Blvd. Oklahoma
City, OK. 73169 (Mail Address: P.O. Box 25082, Oklahoma City, OK 73125)
Telephone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: This rule amends Title 14 of the Code of
Federal Regulations, Part 97 (14 CFR part 97), by establishing,
amending, suspending, or revoking SIAPS, Takeoff Minimums and/or ODPS.
The complete regulators description of each SIAP and its associated
Takeoff Minimums or ODP for an identified airport is listed on FAA form
documents which are incorporated by reference in this amendment under 5
U.S.C. 552(a), 1 CFR part 51, and 14 CFR part 97.20. The applicable FAA
Forms are FAA Forms 8260-3, 8260-4, 8260-5, 8260-15A, and 8260-15B when
required by an entry on 8260-15A.
    The large number of SIAPs, Takeoff Minimums and ODPs, in addition
to their complex nature and the need for a special format make
publication in the Federal Register expensive and impractical.
Furthermore, airmen do not use the regulatory text of the SIAPs,
Takeoff Minimums or ODPs, but instead refer to their depiction on
charts printed by publishers of aeronautical materials. The advantages
of incorporation by reference are realized and publication of the
complete description of each SIAP, Takeoff Minimums and ODP listed on
FAA forms is unnecessary. This amendment provides the affected CFR
sections and specifies the types of SIAPs and the effective dates of
the, associated Takeoff Minimums and ODPs. This amendment also
identifies the airport and its location, the procedure, and the
amendment number.

The Rule

    This amendment to 14 CFR part 97 is effective upon publication of
each separate SIAP, Takeoff Minimums and ODP as contained in the
transmittal. Some SIAP and Takeoff Minimums and textual ODP amendments
may have been issued previously by the FAA in a Flight Data Center
(FDC) Notice to Airmen (NOTAM) as an emergency action of immediate
flight safety relating directly to published aeronautical charts. The
circumstances which created the need for some SIAP and Takeoff Minimums
and ODP amendments may require making them effective in less than 30
days. For the remaining SIAPS and Takeoff Minimums and ODPS, an
effective date at least 30 days after publication is provided.
    Further, the SIAPs and Takeoff Minimums and ODPS contained in this
amendment are based on the criteria contained in the U.S. Standard for
Terminal Instrument Procedures (TERPS). In developing these SIAPS and
Takeoff Minimums and ODPs, the TERPS criteria were applied to the
conditions existing or anticipated at the affected airports. Because of
the close and immediate relationship between these SIAPs, Takeoff
Minimums and ODPs, and safety in air commerce, I find that notice and
public procedures before adopting these SIAPS, Takeoff Minimums and
ODPs are impracticable

and contrary to the public interest and, where applicable, that good
cause exists for making some SIAPs effective in less than 30 days.

Conclusion

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore--(1) is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule '' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26,1979); and
(3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is so minimal. For the same reason, the FAA
certifies that this amendment will not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 97

    Air Traffic Control, Airports, Incorporation by reference, and
Navigation (Air).

    Issued in Washington, DC, on January 6, 2012.
John M. Allen,
Director, Flight Standards Service.

Adoption of the Amendment

    Accordingly, pursuant to the authority delegated to me, Title 14,
Code of Federal Regulations, part 97 (14 CFR part 97) is amended by
establishing, amending, suspending, or revoking Standard Instrument
Approach Procedures and/or Takeoff Minimums and/or Obstacle Departure
Procedures effective at 0902 UTC on the dates specified, as follows:

PART 97--STANDARD INSTRUMENT APPROACH PROCEDURES

0
1. The authority citation for part 97 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40103, 40106, 40113, 40114, 40120,
44502, 44514, 44701, 44719, 44721-44722.

0
2. Part 97 is amended to read as follows:

Effective 9 FEB 2012

Gadsden, AL, Northeast Alabama Rgnl, Takeoff Minimums and Obstacle
DP, Amdt 4
Phoenix, AZ, Phoenix Sky Harbor Intl, ILS OR LOC RWY 7R, Amdt 2
Phoenix, AZ, Phoenix Sky Harbor Intl, ILS OR LOC 25L, Amdt 1E
Tracy, CA, Tracy Muni, RNAV (GPS) RWY 12, Amdt 1
Longmont, CO, Vance Brand, RNAV (GPS)-B, Amdt 1
Longmont, CO, Vance Brand, Takeoff Minimums and Obstacle DP, Amdt 1
Longmont, CO, Vance Brand, VOR/DME-A, Amdt 2
Windsor Locks, CT, Bradley Intl, RNAV (GPS) RWY 33, Amdt 2A
Washington, DC, Ronald Reagan Washington National, Takeoff Minimums
and Obstacle DP, Amdt 7
Fort Pierce, FL, St Lucie County Intl, RNAV (GPS) RWY 14, Amdt 1
Fort Pierce, FL, St Lucie County Intl, RNAV (GPS) RWY 32, Amdt 1
Fort Pierce, FL, St Lucie County Intl, VOR/DME RWY 14, Amdt 9
Titusville, FL, Arthur Dunn Air Park, GPS RWY 15, Orig-B, CANCELLED
Titusville, FL, Arthur Dunn Air Park, GPS RWY 33, Orig-B, CANCELLED
Titusville, FL, Arthur Dunn Air Park, RNAV (GPS) RWY 15, Orig
Titusville, FL, Arthur Dunn Air Park, RNAV (GPS) RWY 33, Orig
West Palm Beach, FL, Palm Beach Intl, ILS OR LOC RWY 10L, Amdt 26
West Palm Beach, FL, Palm Beach Intl, RNAV (GPS) Y RWY 10L, Amdt 3
West Palm Beach, FL, Palm Beach Intl, RNAV (RNP) Z RWY 10L, Amdt 1
Perry, IA, Perry Muni, GPS RWY 14, Orig-B, CANCELLED
Perry, IA, Perry Muni, RNAV (GPS) RWY 14, Orig
Perry, IA, Perry Muni, RNAV (GPS) RWY 32, Amdt 1
Belleville, IL, Scott AFB/Midamerica, ILS OR LOC/DME RWY 32L, Amdt 1
Belleville, IL, Scott AFB/Midamerica, TACAN RWY 14R, Amdt 1
Belleville, IL, Scott AFB/Midamerica, TACAN RWY 32L, Amdt 1
Chicago/Prospect Heights/Wheeling, IL, Chicago Executive, RNAV (GPS)
RWY 16, Amdt 1
Chicago/West Chicago, IL, Dupage, ILS OR LOC RWY 10, Amdt 8
Decatur, IL, Decatur, RNAV (GPS) RWY 12, Orig
Decatur, IL, Decatur, RNAV (GPS) RWY 30, Amdt 1
Moline, IL, Quad City Intl, ILS OR LOC RWY 9, Amdt 31
Moline, IL, Quad City Intl, RNAV (GPS) RWY 9, Amdt 1
Moline, IL, Quad City Intl, RNAV (GPS) RWY 27, Amdt 1
Moline, IL, Quad City Intl, RNAV (GPS) Y RWY 27, Orig, CANCELLED
Augusta, KS, Augusta Muni, VOR/DME-A, Amdt 1
Plymouth, MA, Plymouth Muni, ILS OR LOC/DME RWY 6, Amdt 1A
Fort Meade (Odenton), MD, Tipton, VOR-A, Amdt 1, CANCELLED
Brunswick, ME, Brunswick Executive, ILS OR LOC/DME RWY 1R, Orig
Battle Creek, MI, W K Kellogg, RNAV (GPS) RWY 31, Orig
Battle Creek, MI, W K Kellogg, VOR OR TACAN OR GPS RWY 31, Amdt 14
CANCELLED
Cook, MN, Cook Muni, RNAV (GPS) RWY 13, Orig
Cook, MN, Cook Muni, RNAV (GPS) RWY 31, Amdt 1
Ely, MN, Ely Muni, RNAV (GPS) RWY 12, Amdt 1
Ely, MN, Ely Muni, RNAV (GPS) RWY 30, Amdt 1
Worthington, MN, Worthington Muni, ILS OR LOC RWY 29, Orig-B
Asheboro, NC, Asheboro Muni, NDB RWY 21, Amdt 3, CANCELLED
Raleigh/Durham, NC, Raleigh-Durham Intl, NDB RWY 23L, Amdt 5,
CANCELLED
Rockingham, NC, Richmond County, NDB RWY 32, Amdt 3B, CANCELLED
Siler City, NC, Siler City Muni, NDB RWY 22, Amdt 1, CANCELLED
Morristown, NJ, Morristown Muni, RNAV (GPS) RWY 5, Amdt 3
Aiken, SC, Aiken Muni, ILS OR LOC/DME RWY 7, Orig
Aiken, SC, Aiken Muni, LOC RWY 7, Orig, CANCELLED
Aiken, SC, Aiken Muni, RNAV (GPS) RWY 7, Amdt 1
Aiken, SC, Aiken Muni, RNAV (GPS) RWY 25, Amdt 1
Spartanburg, SC, Spartanburg Downtown Memorial, ILS OR LOC RWY 5,
Amdt 1A
Bristol/Johnson/Kingsport, TN, Tri-Cities Rgnl TN/VA, ILS OR LOC RWY
5, Amdt 3
Bristol/Johnson/Kingsport, TN, Tri-Cities Rgnl TN/VA, RNAV (GPS) RWY
5, Amdt 1
Bristol/Johnson/Kingsport, TN, Tri-Cities Rgnl TN/VA, RNAV (GPS) RWY
23, Amdt 1
Bristol/Johnson/Kingsport, TN, Tri-Cities Rgnl TN/VA, RNAV (GPS) Y
RWY 23, Orig, CANCELLED
Springfield, TN, Springfield Robertson County, LOC RWY 4, Amdt 3
Springfield, TN, Springfield Robertson County, RNAV (GPS) RWY 4,
Amdt 1
Springfield, TN, Springfield Robertson County, RNAV (GPS) RWY 22,
Amdt 1
Springfield, TN, Springfield Robertson County, Takeoff Minimums and
Obstacle DP, Amdt 1
Houston, TX, Ellington Field, ILS OR LOC RWY 17R, Amdt 6
Houston, TX, Ellington Field, ILS OR LOC RWY 22, Amdt 3E
Houston, TX, Ellington Field, ILS OR LOC RWY 35L, Amdt 5B
Houston, TX, Ellington Field, RNAV (GPS) RWY 4, Amdt 1A
Houston, TX, Ellington Field, RNAV (GPS) RWY 35L, Orig-B
Houston, TX, Ellington Field, TACAN RWY 17R, Orig
Houston, TX, Ellington Field, TACAN RWY 22, Orig
Houston, TX, George Bush Intercontinental/Houston, ILS OR LOC RWY
26L, ILS RWY 26L (CAT II), ILS RWY 26L (CAT III), ILS RWY 26L (SA
CAT I), Amdt 20
Houston, TX, George Bush Intercontinental/Houston, ILS OR LOC RWY
26R, ILS RWY 26R (CAT II), ILS RWY 26R (CAT III), ILS RWY 26R (SA
CAT I), Amdt 3
Houston, TX, George Bush Intercontinental/Houston, ILS OR LOC RWY
27, ILS RWY 27 (CAT II), ILS RWY 27 (CAT III), ILS RWY 27 (SA CAT
I), Amdt 9
Houston, TX, George Bush Intercontinental/Houston, RNAV (GPS) Z RWY
26L, Amdt 3
Houston, TX, George Bush Intercontinental/Houston, RNAV (GPS) Z RWY
26R, Amdt 3

Houston, TX, George Bush Intercontinental/Houston, RNAV (GPS) Z RWY
27, Amdt 3
Bryce Canyon, UT, Bryce Canyon, RNAV (GPS) RWY 21, Amdt 1
St. George, UT, St. George Muni, LDA/DME RWY 19, Orig-A
St. George, UT, St. George Muni, RNAV (GPS) RWY 19, Orig-A
Franklin, VA, Franklin Muni-John Beverly Rose, RNAV (GPS) RWY 9,
Amdt 1
Franklin, VA, Franklin Muni-John Beverly Rose, RNAV (GPS) RWY 27,
Amdt 1
Williamson, WV, Mingo County Rgnl, RNAV (GPS) RWY 8, Orig
Williamson, WV, Mingo County Rgnl, RNAV (GPS) RWY 26, Orig
[FR Doc. 2012-804 Filed 1-20-12; 8:45 am]
BILLING CODE 4910-13-P


MEMORANDUM  SEQ CHAPTER \h \r 1

DATE:		July 29, 2015

TO:		Clean Power Plan for Existing Power Plants; Docket Id: OAR–2013-0602

FROM:		Lora Strine, EPA

SUBJECT:	July 28, 2015 Phone Call Regarding Proposed Clean Power Plan for Existing Power Plants

SUMMARY

A phone call was held between EPA and Gabe Pacyniak, GCC on July 28, 2015 to discuss the proposed Clean Power Plan for Existing Power Plants. The Clean Power Plan for Existing Power Plants was proposed on June 2, 2014.

ATTENDEES

Georgetown Climate Center

Gabe Pacyniak

US EPA

Lora Strine

Jeremy Tarr


[Federal Register Volume 88, Number 238 (Wednesday, December 13, 2023)]
[Notices]
[Pages 86345-86346]
[FR Doc No: 2023-27303]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-0008]

Request for Nominations of Individuals and Industry Organizations
for the Genetic Metabolic Diseases Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is requesting
that industry organizations interested in participating in the
selection of a nonvoting industry representative to serve on the
Genetic Metabolic Diseases Advisory Committee (the Committee) in the
Center for Drug Evaluation and Research notify FDA in writing. FDA is
also requesting nominations for a nonvoting industry representative to
serve on the Committee. Nominees recommended to serve as a nonvoting
industry representative may either be self-nominated or nominated by an
industry organization. Nominations will be accepted for the current
vacancy effective with this notice.

DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interest, must send a letter stating that interest to the FDA by
February 12, 2024, (see sections I and II of this document for
details). Concurrently, nomination materials for prospective candidates
should be sent to FDA by February 12, 2024.

ADDRESSES: All statements of interest from interested industry
organizations interested in participating in the selection process of a
nonvoting industry representative should be sent electronically to
Nicholas Marsh (see FOR FURTHER INFORMATION CONTACT). All nominations
for the nonvoting industry representative may be submitted
electronically by accessing the FDA Advisory Committee Membership
Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and
Management Staff, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002.
    Information about becoming a member on an FDA advisory committee
can also be obtained by visiting FDA's website at https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Nicolas Marsh, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2418, Silver Spring, MD 20993-0002, 240-
402-5357, email: [email protected].
    For questions relating to the Genetic Metabolic Diseases Advisory
Committee: Moon Choi, Center for Drug Evaluation and Research, Food and
Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417,
Silver Spring, MD 20993-0002,<PHONE_NUMBER>, email: [email protected].

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for a
nonvoting industry representative for the Genetic Metabolic Diseases
Advisory Committee.
    Elsewhere in this issue of the Federal Register, FDA is publishing
separate documents regarding:

1. Genetic Metabolic Diseases Advisory Committee; Notice of
Establishment
2. Request for Nominations for Voting Members for the Genetic Metabolic
Diseases Advisory Committee
3. Request for Nominations of Individuals and Consumer Organizations
for the Genetic Metabolic Diseases Advisory Committee

I. General Description of the Genetic Metabolic Diseases Advisory
Committee's Duties

    The Committee reviews and evaluates data on the safety and
effectiveness of marketed and investigational human drug and biologic
products for use in the treatment of genetic metabolic diseases and
makes appropriate recommendations to the Commissioner of Food and
Drugs.

II. Qualifications

    Persons nominated for the Committee should be full-time employees
of firms that develop human drug and biologic products, or consulting
firms that represent human drug and biologic product developers or have
similar appropriate ties to industry.

III. Selection Procedure

    Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interest must send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document (see DATES). Within the subsequent 60 days, FDA will send
a letter to each organization that has expressed an interest, attaching
a complete list of all such organizations; and a list of all nominees
along with their current r[eacute]sum[eacute]s or curriculum vitae. The
letter will also state that it is the responsibility of the interested
organizations to confer with one another and to select a candidate, to
represent industry interest for the committee, within 60 days after the
receipt of the FDA letter. The interested organizations are not bound
by the list of nominees in selecting a candidate. However, if no
individual is selected within 60 days, the Commissioner will select
temporary nonvoting members to represent industry interests.

IV. Nomination Procedure

    Individuals may self-nominate and/or an organization may nominate
one or more individuals to serve as a temporary nonvoting industry
representative. Nominations must include a cover letter and a current,
complete r[eacute]sum[eacute] or curriculum vitae for each nominee,
including current business and/or home address, telephone number, and
email address if available; and a signed copy of the Acknowledgement
and Consent form available at the FDA Advisory Committee Membership
Nomination Portal (see ADDRESSES). Nominations should specify the
advisory committee for which the nominee is recommended within 60 days
of publication of this document (see DATES). Nominations should also
acknowledge that the nominee is aware of the nomination, unless self-
nominated. FDA will forward all nominations to the organizations
expressing interest in participating in the selection process for the
committee. Only interested industry organizations participate in the
selection process. Persons who nominate themselves as nonvoting
industry representatives will not participate in the selection process.
    FDA seeks to include the views of members of all gender groups,
members of all racial and ethnic groups, and individuals with and
without disabilities on its advisory committees and, therefore
encourages nominations of appropriately qualified candidates from these
groups.
    This notice is issued under the Federal Advisory Committee Act (5
U.S.C. 1001 et seq.) and 21 CFR part 14, relating to advisory
committees.

    Dated: December 7, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-27303 Filed 12-12-23; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Page 14723]
[FR Doc No: 2017-05719]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9959-97-OARM]

National and Governmental Advisory Committees

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public advisory committee meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92-
463, notice is hereby given that the National Advisory Committee and
the Governmental Advisory Committee will hold a public meeting on
Tuesday, March 28 and Wednesday, March 29, 2017 in Washington, DC. The
meeting is open to the public. Due to unforeseen administrative
circumstances, EPA is announcing this meeting with less than 15
calendar days notice.

DATES: The National and Governmental Advisory Committees will hold an
open meeting on Tuesday, March 28, 2017 from 9:00 a.m. to 5:30 p.m.,
and Wednesday, March 29, 2017 from 9:00 a.m. until 3:00 p.m.
    Purpose of Meeting: The purpose of the meeting is to provide advice
on the draft CEC 2017-18 Operational Plan and to discuss other trade
and environment issues in North America. The meeting will also include
a public comment session.

ADDRESSES: The meeting will be held at the U.S. EPA, Conference Room
2138, located in the William Jefferson Clinton South Building, 1200
Pennsylvania Ave. NW., Washington, DC 20004. Telephone:<PHONE_NUMBER>.
The meeting is open to the public, with limited seating on a first-
come, first-served basis.
    General Information: The agenda, meeting materials, and general
information about the NAC and GAC will be available at http://www2.epa.gov/faca/nac-gac. If you wish to make oral comments or submit
written comments to the NAC/GAC please contact Oscar Carrillo at least
five days prior to the meeting at<EMAIL_ADDRESS>    Meeting Access: For information on access or services for
individuals with disabilities, please contact Oscar Carrillo at 202-
564-0347 or<EMAIL_ADDRESS>To request accommodation of a
disability, please contact Oscar Carrillo, preferably at least 10 days
prior to the meeting, to give EPA as much time as possible to process
your request.

    Dated: February 28, 2017.
Oscar Carrillo,
Designated Federal Officer.
[FR Doc. 2017-05719 Filed 3-21-17; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 233 (Wednesday, December 4, 2013)]
[Notices]
[Pages 72876-72877]
[FR Doc No: 2013-28925]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP14-207-000.
    Applicants: Transcontinental Gas Pipe Line Company.
    Description: S-2 Tracker Filing Effective 2013-12-01 to be
effective 12/1/2013.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5074
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-208-000.
    Applicants: Southern Natural Gas Company, L.L.C.
    Description: SCRM Report of Southern Natural Gas Company, L.L.C.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5082.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-209-000.
    Applicants: Mojave Pipeline Company, L.L.C.
    Description: Annual Fuel and L&U Effective 1--1--14 to be effective
1/1/2014.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5122.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-210-000.
    Applicants: El Paso Natural Gas Company, L.L.C.
    Description: Article 11.2(a) Annual Inflation Adjustment Filing to
be effective 1/1/2014.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5124.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-211-000.
    Applicants: Cameron Interstate Pipeline, LLC.
    Description: Cameron Interstate Pipeline, LLC submits tariff filing
per 154.402: Cameron Interstate Pipeline Annual Adjustment of Fuel
Retainage Percentage to be effective 11/25/2013.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5150.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-212-000.
    Applicants: Natural Gas Pipeline Company of America.
    Description: Natural Gas Pipeline Company of America LLC submits
tariff filing per 154.204: Negotiated Rate Filing--BP Canada Amendment
to be effective 12/1/2013.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5156.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-213-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: Iroquois Gas Transmission System, L.P. submits tariff
filing per 154.204: 11/25/13 Negotiate Rates--JP Morgan Ventures Energy
Corp (HUB) 6025-89 to be effective 11/24/2013.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5233.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-214-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: Iroquois Gas Transmission System, L.P. submits tariff
filing per 154.204: 11/25/13 Negotiated Rates--Sequent Energy
Management (HUB) 3075-89 to be effective 11/24/2013.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5234.
    Comments Due: 5 p.m. ET 12/9/13.

    Docket Numbers: RP14-215-000.
    Applicants: Tennessee Gas Pipeline Company, L.L.C.
    Description: Tennessee Gas Pipeline Company, L.L.C. 2012-2013
Cashout Report.
    Filed Date: 11/25/13.
    Accession Number: 20131125-5245.
    Comments Due: 5 p.m. ET 12/9/13.

    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.

Filings in Existing Proceedings

    Docket Numbers: RP13-941-003.
    Applicants: Southern Star Central Gas Pipeline, Inc.
    Description: Southern Star Central Gas Pipeline, Inc. submits
tariff filing per 154.203: Rate Case (RP13-941) Motion Filing to be
effective 12/1/2013.
    Filed Date: 11/26/13.
    Accession Number: 20131126-5021.
    Comments Due: 5 p.m. ET 12/9/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.

    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: November 26, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-28925 Filed 12-3-13; 8:45 am]
BILLING CODE 6717-01-P


                                                         UNITED STATES ENVIRONMENTAL PROTECTION AGENCY                             WASHINGTON, D.C.  20460

 								 OFFICE OF POLICY

MEMORANDUM

SUBJECT:	Transmittal to Docket:  Summary of the March 16, 2011, Public Meeting in Philadelphia, Pennsylvania, regarding the Environmental Protection Agency's Implementation of Executive Order 13563:  Improving Regulation and Regulatory Review

FROM:	Stuart C. Miles-McLean 		Office of Regulatory Policy and Management

TO: 		Public Docket #EPA-HQ-OA-2011-0156:  Improving Regulations:  General                     As called for by President Obama in Executive Order 13563, "to facilitate the periodic review of existing significant regulations," the Environmental Protection Agency (EPA) is considering "how best to promote retrospective analysis of rules that may be outmoded, ineffective, insufficient, or excessively burdensome, and to modify, streamline, expand, or repeal them in accordance with what has been learned."                As part of its retrospective review of regulations, EPA convened public meetings around the country to gather input on how we might design the plan we will use to periodically review our regulations.  This Memo transmits to the docket a summary of the public meeting held on March 16, 2011, in Philadelphia, Pennsylvania.


[Federal Register Volume 77, Number 53 (Monday, March 19, 2012)]
[Notices]
[Page 16027]
[FR Doc No: 2012-6514]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER12-1223-000]

Wildcat Wind, LLC; Supplemental Notice That Initial Market-Based
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding of
Wildcat Wind, LLC's application for market-based rate authority, with
an accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is April 2, 2012.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: March 13, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-6514 Filed 3-16-12; 8:45 am]
BILLING CODE 6717-01-P


<!DOCTYPE HTML PUBLIC "-//-//W3C//DTD HTML 3.2//EN">

<META name="generator" content="PDFCreactiveX HTML Export">
<META name="creation-date" content="25/04/2008 12:19:58 ">
<TITLE></TITLE>


[Federal Register Volume 85, Number 149 (Monday, August 3, 2020)]
[Notices]
[Pages 46659-46662]
[FR Doc No: 2020-16846]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-4119]

Food Safety Modernization Act Third-Party Certification Program
User Fee Rate for Fiscal Year 2021

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
fiscal year (FY) 2021 annual fee rate for recognized accreditation
bodies and accredited certification bodies, and the fee rate for
accreditation bodies applying to be recognized in the third-party
certification program that is authorized by the Federal Food, Drug, and
Cosmetic Act (FD&C Act), as amended by the FDA Food Safety
Modernization Act (FSMA). We are also announcing the fee rate for
certification bodies that are applying to be directly accredited by
FDA.

DATES: This fee is effective October 1, 2020.

FOR FURTHER INFORMATION CONTACT: Donald Prater, Office of Food Policy
and Response, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 1, Rm. 3202, Silver Spring, MD 20993,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    Section 307 of FSMA, Accreditation of Third-Party Auditors, amended
the FD&C Act to create a new provision, section 808, under the same
name. Section 808 of the FD&C Act (21 U.S.C. 384d) directs FDA to
establish a program for accreditation of third-party certification
bodies \1\ conducting food safety audits and issuing food and facility
certifications to eligible foreign entities (including registered
foreign food facilities) that meet our applicable requirements. Under
this provision, we established a system for FDA to recognize
accreditation bodies to accredit certification bodies, except for
limited circumstances in which we may directly accredit certification
bodies to participate in the third-party certification program.
---------------------------------------------------------------------------

    \1\ For the reasons explained in the third-party certification
final rule (80 FR 74570 at 74578-74579, November 27, 2015), and for
consistency with the implementing regulations for the third-party
certification program in 21 CFR parts 1, 11, and 16, this notice
uses the term ``third-party certification body'' rather than the
term ``third-party auditor'' used in section 808(a)(3) of the FD&C
Act.
---------------------------------------------------------------------------

    Section 808(c)(8) of the FD&C Act directs FDA to establish a
reimbursement (user fee) program by which we assess fees and require
reimbursement for the work FDA performs to establish and administer the
third-party certification program under section 808 of the FD&C Act.
The user fee program for the third-party certification program was
established by a final rule entitled ``Amendments to Accreditation of
Third-Party Certification Bodies To Conduct Food Safety Audits and To
Issue Certifications To Provide for the User Fee Program'' (81 FR
90186, December 14, 2016).
    The FSMA FY 2021 third-party certification program user fee rate
announced in this notice is effective on October 1, 2020, and will
remain in effect through September 30, 2021.

II. Estimating the Average Cost of a Supported Direct FDA Work Hour for
FY 2021

    FDA must estimate its costs for each activity in order to establish
fee rates for FY 2021. In each year, the costs of salary (or personnel
compensation) and benefits for FDA employees account for between 50 and
60 percent of the funds available to, and used by, FDA. Almost all of
the remaining funds (operating funds) available to FDA are used to
support FDA employees for paying rent, travel, utility, information
technology, and other operating costs.

A. Estimating the Full Cost per Direct Work Hour in FY 2021

    Full-time Equivalent (FTE) reflects the total number of regular
straight-time hours--not including overtime or holiday hours--worked by
employees, divided by the number of compensable hours applicable to
each fiscal year. Annual leave, sick leave, compensatory time off, and
other approved leave categories are considered ``hours worked'' for
purposes of defining FTE employment.
    In general, the starting point for estimating the full cost per
direct work hour is to estimate the cost of an FTE or paid staff year.
Calculating an Agency-wide total cost per FTE requires three primary
cost elements: payroll, non-payroll, and rent.

    We have used an average of past year cost elements to predict the
FY 2021 cost. The FY 2021 FDA-wide average cost for payroll (salaries
and benefits) is $164,103; non-payroll--including equipment, supplies,
information technology, general and administrative overhead--is
$94,685; and rent, including cost allocation analysis and adjustments
for other rent and rent-related costs, is $25,386 per paid staff year,
excluding travel costs.
    Summing the average cost of an FTE for payroll, non-payroll, and
rent, brings the FY 2021 average fully supported cost to $284,174 per
FTE, excluding travel costs. FDA will use this base unit fee in
determining the hourly fee rate for third-party certification user fees
for FY 2021 prior to including travel costs as applicable for the
activity.
    To calculate an hourly rate, FDA must divide the FY 2021 average
fully supported cost of $ 284,174 per FTE by the average number of
supported direct FDA work hours in FY 2019--the last FY for which data
are available. See Table 1.

Table 1--Supported Direct FDA Work Hours in a Paid Staff Year in FY 2019
------------------------------------------------------------------------

------------------------------------------------------------------------
Total number of hours in a paid staff year.................        2,080
Less:
  10 paid holidays.........................................          -80
20 days of annual leave....................................         -160
10 days of sick leave......................................          -80
12.5 days of training......................................         -100
26.5 days of general administration........................         -184
26.5 days of travel........................................         -212
2 hours of meetings per week...............................         -104
Net Supported Direct FDA Work Hours Available for                  1,160
 Assignments...............................................
------------------------------------------------------------------------

    Dividing the average fully supported FTE cost in FY 2021 ($284,174)
by the total number of supported direct work hours available for
assignment in FY 2019 (1,160) results in an average fully supported
cost of $245 (rounded to the nearest dollar), excluding travel costs,
per supported direct work hour in FY 2021.

B. Adjusting FY 2019 Travel Costs for Inflation to Estimate FY 2021
Travel Costs

    To adjust the hourly rate for FY 2021, FDA must estimate the cost
of inflation in each year for FY 2020 and FY 2021. FDA uses the method
prescribed for estimating inflationary costs under the Prescription
Drug User Fee Act (PDUFA) provisions of the FD&C Act (section 736(c)(1)
(21 U.S.C. 379h(c)(1))), the statutory method for inflation adjustment
in the FD&C Act that FDA has used consistently. FDA previously
determined the FY 2020 inflation rate to be 2.3964 percent; this rate
was published in the FY 2020 PDUFA user fee rates notice in the Federal
Register (August 2, 2019, 84 FR 37882). Utilizing the method set forth
in section 736(c)(1) of the FD&C Act, FDA has calculated an inflation
rate of 2.3964 percent for FY 2020 and 1.3493 percent for FY 2021, and
FDA intends to use this inflation rate to make inflation adjustments
for FY 2021; the derivation of this rate will be published in the
Federal Register in the FY 2021 notice for the PDUFA user fee rates.
The compounded inflation rate for FYs 2020 and 2021, therefore, is
1.037780 (or 3.7780 percent) (calculated as 1 plus 2.3964 percent times
1 plus 1.3493 percent).
    The average fully supported cost per supported direct FDA work
hour, excluding travel costs, of $245 already takes into account
inflation as the calculation above is based on FY 2021 predicted costs.
FDA will use this base unit fee in determining the hourly fee rate for
third-party certification program fees for FY 2021 prior to including
travel costs as applicable for the activity. For the purpose of
estimating the fee, we are using the travel cost rate for foreign
travel because we anticipate that the vast majority of onsite
assessments made by FDA under this program will require foreign travel.
In FY 2019, the Office of Regulatory Affairs spent a total of
$3,506,000 on 463 foreign inspection trips related to FDA's Center for
Food Safety and Applied Nutrition and Center for Veterinary Medicine
field activities programs, which averaged a total of $7,572 per foreign
inspection trip. These trips averaged 3 weeks (or 120 paid hours) per
trip. Dividing $7,572 per trip by 120 hours per trip results in a total
and an additional cost of $63 (rounded to the nearest dollar) per paid
hour spent for foreign inspection travel costs in FY 2019. To adjust
$63 for inflationary increases in FY 2020 and FY 2021, FDA must
multiply it by the same inflation factor mentioned previously in this
document (1.037780 or 3.7780 percent), which results in an estimated
cost of $65 (rounded to the nearest dollar) per paid hour in addition
to $245 for a total of $310 per paid hour ($245 plus $65) for each
direct hour of work requiring foreign inspection travel. FDA will use
this rate in charging fees in FY 2021 when travel is required for the
third-party certification program.

                 Table 2--FSMA Fee Schedule for FY 2021
------------------------------------------------------------------------
                                                           Fee rates for
                      Fee category                            FY 2021
------------------------------------------------------------------------
Hourly rate without travel..............................            $245
Hourly rate if travel is required.......................             310
------------------------------------------------------------------------

III. Fees for Accreditation Bodies and Certification Bodies in the
Third-Party Certification Program Under Section 808(c)(8) of the FD&C
Act

    The third-party certification program assesses application fees and
annual fees. In FY 2021, the only fees that could be collected by FDA
under section 808(c)(8) of the FD&C Act are the initial application fee
for accreditation bodies seeking recognition, the annual fee for
recognized accreditation bodies, the annual fee for certification
bodies accredited by a recognized accreditation body, and the initial
application fee for a certification body seeking direct accreditation
from FDA. Table 3 provides an overview of the fees for FY 2021.

Table 3--FSMA Third-Party Certification Program User Fee Schedule for FY
                                  2021
------------------------------------------------------------------------
                                                           Fee rates for
                      Fee category                            FY 2021
------------------------------------------------------------------------
Initial Application Fee for Accreditation Body Seeking           $42,320
 Recognition............................................
Annual Fee for Recognized Accreditation Body............           1,966
Annual Fee for Accredited Certification Body............           2,458
Initial Application Fee for a Certification Body Seeking          42,320
 Direct Accreditation from FDA..........................
------------------------------------------------------------------------

A. Application Fee for Accreditation Bodies Applying for Recognition in
the Third-Party Certification Program Under Section 808(c)(8) of the
FD&C Act

    Section 1.705(a)(1) (21 CFR 1.705(a)(1)) establishes an application
fee for accreditation bodies applying for initial recognition that
represents the estimated average cost of the work FDA performs in
reviewing and evaluating initial applications for recognition of
accreditation bodies.
    The fee is based on the fully supported FTE hourly rates and
estimates of the number of hours it would take FDA to perform relevant
activities. These estimates represent FDA's current thinking, and as
the program evolves, FDA will continue to reconsider the estimated
hours. Based on data we have acquired since starting the program, we
estimate that it would take, on average, 80 person-hours to review an
accreditation body's

submitted application, 48 person-hours for an onsite performance
evaluation of the applicant (including travel and other steps necessary
for a fully supported FTE to complete an onsite assessment), and 32
person-hours to prepare a written report documenting the onsite
assessment.
    FDA employees review applications and prepare reports from their
worksites, so we use the fully supported FTE hourly rate excluding
travel, $245/hour, to calculate the portion of the user fee
attributable to those activities: $245/hour x (80 hours (application
review) + 32 hours (written report)) = $27,440. FDA employees will
likely travel to foreign countries for the onsite performance
evaluations because most accreditation bodies are anticipated to be
located in foreign countries. For this portion of the fee we use the
fully supported FTE hourly rate for work requiring travel, $310/hour,
to calculate the portion of the user fee attributable to those
activities: $310/hour x 48 hours (i.e., two fully supported FTEs x ((2
travel days x 8 hours) + (1 day onsite x 8 hours))) = $14,880. The
estimated average cost of the work FDA performs in total for reviewing
an initial application for recognition for an accreditation body based
on these figures would be $27,440 + $14,880 = $42,320. Therefore, the
application fee for accreditation bodies applying for recognition in FY
2021 will be $42,320.

B. Annual Fee for Accreditation Bodies Participating in the Third-Party
Certification Program Under Section 808(c)(8) of the FD&C Act

    To calculate the annual fee for each recognized accreditation body,
FDA takes the estimated average cost of work FDA performs to monitor
performance of a single recognized accreditation body and annualizes
that over the average term of recognition. At this time, we assume an
average term of recognition of 5 years. We also assume that FDA will
monitor 10 percent of recognized accreditation bodies onsite. As the
program proceeds, we will adjust the term of recognition as
appropriate. We estimate that for one performance evaluation of a
recognized accreditation body, it would take, on average (taking into
account that not all recognized accreditation bodies would be monitored
onsite), 22 hours for FDA to conduct records review, 8 hours to prepare
a report detailing the records review and onsite performance
evaluation, and 8 hours of onsite performance evaluation. Using the
fully supported FTE hourly rates in Table 2, the estimated average cost
of the work FDA performs to monitor performance of a single recognized
accreditation body would be $7,350 ($245/hour x (22 hours (records
review) + 8 hours (written report))) plus $2,480 ($310/hour x 8 hours
(on-site evaluation)), which is $9,830. Annualizing this amount over 5
years would lead to an annual fee for recognized accreditation bodies
of $1,966 for FY 2021.

C. Annual Fee for Certification Bodies Accredited by a Recognized
Accreditation Body in the Third-Party Certification Program Under
Section 808(c)(8) of the FD&C Act

    To calculate the annual fee for a certification body accredited by
a recognized accreditation body, FDA takes the estimated average cost
of work FDA performs to monitor performance of a single certification
body accredited by a recognized accreditation body and annualizes that
over the average term of accreditation. At this time, we assume an
average term of accreditation of 4 years. This fee is based on the
fully supported FTE hourly rates and estimates of the number of hours
it would take FDA to perform relevant activities. We estimate that FDA
would conduct, on average, the same activities, for the same amount of
time to monitor certification bodies accredited by a recognized
accreditation body as we would to monitor an accreditation body
recognized by FDA. Using the fully supported FTE hourly rates in Table
2, the estimated average cost of the work FDA performs to monitor
performance of a single accredited certification body would be $7,350
($245/hour x (22 hours (records review) + 8 hours (written report)))
plus $2,480 ($310/hour x 8 hours (on-site evaluation)), which is
$9,830. Annualizing this amount over 4 years would lead to an annual
fee for accredited certification bodies of $2,458 for FY 2021.

D. Initial Application Fee for Certification Bodies Seeking Direct
Accreditation from FDA in the Third-Party Certification Program Under
Section 808(c)(8) of the FD&C Act

    Section 1.705(a)(3) establishes an application fee for
certification bodies applying for direct accreditation from FDA that
represents the estimated average cost of the work FDA performs in
reviewing and evaluating initial applications for direct accreditation
of certification bodies.
    The fee is based on the fully supported FTE hourly rates and
estimates of the number of hours it would take FDA to perform relevant
activities. These estimates represent FDA's current thinking, and as
the program evolves, FDA will reconsider the estimated hours. We
estimate that it would take, on average, 80 person-hours to review a
certification body's submitted application, 48 person-hours for an
onsite performance evaluation of the applicant (including travel and
other steps necessary for a fully supported FTE to complete an onsite
assessment), and 32 person-hours to prepare a written report
documenting the onsite assessment.
    FDA employees are likely to review applications and prepare reports
from their worksites, so we use the fully supported FTE hourly rate
excluding travel, $245/hour, to calculate the portion of the user fee
attributable to those activities: $245/hour x (80 hours (application
review) + 32 hours (written report)) = $27,440. FDA employees will
likely travel to foreign countries for the onsite performance
evaluations because most certification bodies are anticipated to be
located in foreign countries. For this portion of the fee we use the
fully supported FTE hourly rate for work requiring travel, $310/hour,
to calculate the portion of the user fee attributable to those
activities: $310/hour x 48 hours (i.e., two fully supported FTEs x ((2
travel days x 8 hours) + (1 day onsite x 8 hours))) = $14,880. The
estimated average cost of the work FDA performs in total for reviewing
an initial application for direct accreditation of a certification body
based on these figures would be $27,440 + $14,880 = $42,320. Therefore,
the application fee for certification bodies applying for direct
accreditation from FDA in FY 2021 will be $42,320.

IV. Estimated Fees for Accreditation Bodies and Certification Bodies in
Other Fee Categories for FY 2021

    Section 1.705(a) also establishes application fees for recognized
accreditation bodies submitting renewal applications and certification
bodies applying for renewal of direct accreditation. Section 1.705(b)
also establishes annual fees for certification bodies directly
accredited by FDA.
    Although we will not be collecting these other fees in FY 2021, for
transparency and planning purposes, we have provided an estimate of
what these fees would be for FY 2021 based on the fully supported FTE
hourly rates for FY 2021 and estimates of the number of hours it would
take FDA to perform relevant activities as outlined in the Final
Regulatory Impact Analysis for the Third-Party Certification
Regulation. Table 4 provides an overview of the estimated fees for
other fee categories.

  Table 4--Estimated Fee Rates for Other Fee Categories Under the FSMA
                    Third-Party Certification Program
------------------------------------------------------------------------
                                                           Estimated fee
                      Fee category                         rates for FY
                                                               2021
------------------------------------------------------------------------
Renewal application fee for recognized accreditation             $25,195
 body...................................................
Renewal application fee for directly accredited                   25,195
 certification body.....................................
Annual fee for certification body directly accredited by          20,240
 FDA....................................................
------------------------------------------------------------------------

V. How must the fee be paid?

    Accreditation bodies seeking initial recognition must submit the
application fee with the application. For recognized accreditation
bodies and accredited certification bodies, an invoice will be sent
annually. Payment must be made within 30 days of the receipt date. The
payment must be made in U.S. currency from a U.S. bank by one of the
following methods: Wire transfer, electronically, check, bank draft, or
U.S. postal money order made payable to the Food and Drug
Administration. The preferred payment method is online using an
electronic check (Automated Clearing House (ACH), also known as eCheck)
or credit card (Discover, VISA, MasterCard, American Express). Secure
electronic payments can be submitted using the User Fees Payment Portal
at https://userfees.fda.gov/pay. (Note: Only full payments are
accepted. No partial payments can be made online.) Once you have found
your invoice, select ``Pay Now'' to be redirected to Pay.gov.
Electronic payment options are based on the balance due. Payment by
credit card is available only for balances less than $25,000. If the
balance exceeds this amount, only the ACH option is available. Payments
must be made using U.S. bank accounts as well as U.S. credit cards.
When paying by check, bank draft, or U.S. postal money order, please
include the invoice number. Also write the FDA post office box number
(P.O. Box 979108) on the enclosed check, bank draft, or money order.
Mail the payment including the invoice number on the check stub to:
Food and Drug Administration, P.O. Box 979108, St. Louis, MO 63197-
9000. When paying by wire transfer, it is required that the invoice
number is included; without the invoice number the payment may not be
applied. The originating financial institution may charge a wire
transfer fee. If the financial institution charges a wire transfer fee,
it is required to add that amount to the payment to ensure that the
invoice is paid in full. For international wire transfers, please
inquire with the financial institutions prior to submitting the
payment. Use the following account information when sending a wire
transfer: U.S. Department of the Treasury, TREAS NYC, 33 Liberty St.,
New York, NY 10045, Account Name: Food and Drug Administration, Account
No.: 75060099, Routing No.: 021030004, Swift No.: FRNYUS33.
    To send a check by a courier such as Federal Express, the courier
must deliver the check to: U.S. Bank, Attn: Government Lockbox 979108,
1005 Convention Plaza, St. Louis, MO 63101. (Note: This address is for
courier delivery only. If you have any questions concerning courier
delivery, contact U.S. Bank at<PHONE_NUMBER>. This phone number is only
for questions about courier delivery.) The tax identification number of
FDA is 53-0196965. (Note: Invoice copies do not need to be submitted to
FDA with the payments.)

VI. What are the consequences of not paying this fee?

    The consequences of not paying these fees are outlined in 21 CFR
1.725. If FDA does not receive an application fee with an application
for recognition, the application will be considered incomplete and FDA
will not review the application. If a recognized accreditation body
fails to submit its annual user fee within 30 days of the due date, we
will suspend its recognition. If the recognized accreditation body
fails to submit its annual user fee within 90 days of the due date, we
will revoke its recognition. If an accredited certification body fails
to pay its annual fee within 30 days of the due date, we will suspend
its accreditation. If the accredited certification body fails to pay
its annual fee within 90 days of the due date, we will withdraw its
accreditation.

    Dated: July 29, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020-16846 Filed 7-30-20; 11:15 am]
BILLING CODE 4164-01-P


[Federal Register: July 20, 2010 (Volume 75, Number 138)]
[Notices]
[Page 42187]
[DOCID:fr20jy10-118]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Summary Notice No. PE-2010-31]

Petition for Exemption; Summary of Petition Received

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of petition for exemption received.

-----------------------------------------------------------------------

SUMMARY: This notice contains a summary of a petition seeking relief
from specified requirements of 14 CFR. The purpose of this notice is to
improve the public's awareness of, and participation in, this aspect of
FAA's regulatory activities. Neither publication of this notice nor the
inclusion or omission of information in the summary is intended to
affect the legal status of the petition or its final disposition.

DATE: Comments on this petition must identify the petition docket
number involved and must be received on or before August 9, 2010.

ADDRESSES: You may send comments identified by Docket Number FAA-2008-
0348 using any of the following methods:
     Government-wide rulemaking Web site: Go to http://
www.regulations.gov and follow the instructions for sending your
comments electronically.
     Mail: Send comments to the Docket Management Facility;
U.S. Department of Transportation, 1200 New Jersey Avenue, SE., West
Building Ground Floor, Room W12-140, Washington, DC 20590.
     Fax: Fax comments to the Docket Management Facility at
202-493-2251.
     Hand Delivery: Bring comments to the Docket Management
Facility in Room W12-140 of the West Building Ground Floor at 1200 New
Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    Privacy: We will post all comments we receive, without change, to
http://www.regulations.gov, including any personal information you
provide. Using the search function of our docket web site, anyone can
find and read the comments received into any of our dockets, including
the name of the individual sending the comment (or signing the comment
for an association, business, labor union, etc.). You may review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477-78).
    Docket: To read background documents or comments received, go to
http://www.regulations.gov at any time or to the Docket Management
Facility in Room W12-140 of the West Building Ground Floor at 1200 New
Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: Kenna Sinclair, ANM-113, (425) 227-
1556, Federal Aviation Administration, 1601 Lind Avenue, SW, Renton, WA
98057-3356, or Katherine Haley,<PHONE_NUMBER>, Office of Rulemaking
(ARM-203), Federal Aviation Administration, 800 Independence Avenue,
SW., Washington, DC 20591.
    This notice is published pursuant to 14 CFR 11.85.

    Issued in Washington, DC, on July 15, 2010.
Pamela Hamilton-Powell,
Director, Office of Rulemaking.

Petition for Exemption

    Docket No.: FAA-2008-0348.
    Petitioner: The Boeing Company.
    Section of 14 CFR Affected: Sections 25.783(g), 25.8057(a)(1),
25.809(a) and 25.813(a).
    14 CFR Part 25.
    Description of Relief Sought: Boeing requests an amendment to an
existing exemption to allow the main deck entry door of the Model 747-
8F airplane to be used for access to the upper deck supernumerary
seating area.

[FR Doc. 2010-17638 Filed 7-19-10; 8:45 am]
BILLING CODE 4910-13-P